Your first step to apply for a PhD at the MRC Epidemiology is to ensure that you meet all of the University of Cambridge entry requirements. Applicants are encouraged to contact potential supervisors to discuss their research topic.

University of Cambridge Applicant Portal

The online Applicant Portal is the common process for both formal entry to the University and for applying to a number of Cambridge funding schemes (e.g. Cambridge Trust, Gates Cambridge, the Arts & Humanities and Economic & Social Research Councils (AHRC and ESRC), and some other University awards). Please note, the University applies a charge of (GBP Sterling) £65 per application.

You will need to know the following information when completing the Applicant Portal process:

Research Proposal / Covering Letter / CV

You should upload a covering letter which states i) whether you are eligible for MRC full/partial funding, ii) whether you are applying to other funding sources, and iii) an outline of your research interests and how these align with those of the MRC Epidemiology Unit, or which of the highlighted projects you are interested in and why.

Please ALSO upload your CV/Resumé and two academic references.

Please follow the instructions on the Board of Postgraduate Studies website on how to send supporting documents for your University application: Postgraduate School supporting documents guidelines.

PhD in Epidemiology (3 Years)

• Course description: PhD (Probationary) in Medical Science at the MRC Epidemiology Unit (including CEDAR)
• Course Code: MDEU22
• Duration: 3 years
• Study mode: Full-time

In order to be eligible for the different funding schemes you must ensure your University application (Applicant Portal) is submitted and supporting documents are received by the application funding deadlines.

Application deadlines

Closing date for US Gates applicants: Wednesday 13 October 2021 (see Gates Cambridge application timeline for full details)

Closing date for other applicants: Thursday 6 January 2022

Provisional date for Interviews: Monday 27 January 2022